Shenzhen Pengai Hospital Investment Management Co., Ltd.

Shenzhen Pengai Hospital Investment Management Co., Ltd. is a specialized and scaled new professional group institution primarily engaged in hospital investment, management, consulting, and training, and is the main body company of Pengai Medical Aesthetics International Holding Group. Pengai Medical Aesthetics International Holding Group was listed on the main board of the Nasdaq Stock Exchange in New York, USA on October 25, 2019, becoming the first domestically main-board listed medical aesthetics chain institution (stock code: AIH). The group established its first clinic in 1997, which is the predecessor of the current Shenzhen Pengcheng Hospital. After years of development, it now has 10 chain hospitals. The main business of the hospitals covers cosmetic dermatology, cosmetic surgery, micro-plastic surgery, cosmetic traditional Chinese medicine, cosmetic dentistry, and other business segments. The group currently has approximately 1,000 employees, among whom senior and intermediate medical technicians, experts, investment consultants, and senior management personnel account for about 20% of the total workforce. In the tide of the market economy, it has formed its own unique management system and established a good corporate image in society. Adhering to the philosophy of "compliant operation, safe beauty enhancement," the hospitals have been widely praised by all sectors of society and the media for over twenty years and are highly acclaimed by customers. Subsidiary hospitals have received a series of honorary titles and various awards, including "Shenzhen's Most Caring Hospital," "Shenzhen's Safest Hospital," and "China's Top Ten Most Satisfying Consumer Brands," enjoying a good reputation.